新西兰倡导者敦促药房根据病人的需要和治疗进展,扩大获得拯救生命的乳腺癌药物的渠道。 New Zealand advocates urge Pharmac to expand access to a life-saving breast cancer drug due to patient needs and treatment advances.

新西兰药品管理机构药剂师(Pharmac)以病人的需求和治疗进展为例, 推广可能挽救生命的乳癌药物。 Advocates are urging Pharmac, New Zealand’s pharmaceutical management agency, to expand access to a potentially life-saving breast cancer medication, citing patient needs and treatment advancements. 由于一些病人在接受药物方面面临着障碍,尽管在某些情况中已经证明是有效的,但这种推力的出现是因为有些病人在获得药物方面面临着障碍。 The push comes as some patients face barriers to receiving the drug, despite its proven effectiveness in certain cases. 这一呼吁突出了对公平获得创新癌症治疗机会的日益关切。 The call highlights growing concern over equitable access to innovative cancer treatments.